Recombinant DNA Technology Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2017-2028)
2.2 Recombinant DNA Technology Growth Trends by Region
2.2.1 Recombinant DNA Technology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant DNA Technology Historic Market Size by Region (2017-2022)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Region (2023-2028)
2.3 Recombinant DNA Technology Market Dynamics
2.3.1 Recombinant DNA Technology Industry Trends
2.3.2 Recombinant DNA Technology Market Drivers
2.3.3 Recombinant DNA Technology Market Challenges
2.3.4 Recombinant DNA Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA Technology Players by Revenue
3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2017-2022)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2021
3.5 Recombinant DNA Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2017-2022)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2023-2028)
5 Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2017-2022)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Recombinant DNA Technology Market Size (2017-2028)
6.2 North America Recombinant DNA Technology Market Size by Type
6.2.1 North America Recombinant DNA Technology Market Size by Type (2017-2022)
6.2.2 North America Recombinant DNA Technology Market Size by Type (2023-2028)
6.2.3 North America Recombinant DNA Technology Market Share by Type (2017-2028)
6.3 North America Recombinant DNA Technology Market Size by Application
6.3.1 North America Recombinant DNA Technology Market Size by Application (2017-2022)
6.3.2 North America Recombinant DNA Technology Market Size by Application (2023-2028)
6.3.3 North America Recombinant DNA Technology Market Share by Application (2017-2028)
6.4 North America Recombinant DNA Technology Market Size by Country
6.4.1 North America Recombinant DNA Technology Market Size by Country (2017-2022)
6.4.2 North America Recombinant DNA Technology Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2017-2028)
7.2 Europe Recombinant DNA Technology Market Size by Type
7.2.1 Europe Recombinant DNA Technology Market Size by Type (2017-2022)
7.2.2 Europe Recombinant DNA Technology Market Size by Type (2023-2028)
7.2.3 Europe Recombinant DNA Technology Market Share by Type (2017-2028)
7.3 Europe Recombinant DNA Technology Market Size by Application
7.3.1 Europe Recombinant DNA Technology Market Size by Application (2017-2022)
7.3.2 Europe Recombinant DNA Technology Market Size by Application (2023-2028)
7.3.3 Europe Recombinant DNA Technology Market Share by Application (2017-2028)
7.4 Europe Recombinant DNA Technology Market Size by Country
7.4.1 Europe Recombinant DNA Technology Market Size by Country (2017-2022)
7.4.2 Europe Recombinant DNA Technology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA Technology Market Size (2017-2028)
8.2 Asia-Pacific Recombinant DNA Technology Market Size by Type
8.2.1 Asia-Pacific Recombinant DNA Technology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Recombinant DNA Technology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Recombinant DNA Technology Market Share by Type (2017-2028)
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Application
8.3.1 Asia-Pacific Recombinant DNA Technology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Recombinant DNA Technology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Recombinant DNA Technology Market Share by Application (2017-2028)
8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region
8.4.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Recombinant DNA Technology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant DNA Technology Market Size (2017-2028)
9.2 Latin America Recombinant DNA Technology Market Size by Type
9.2.1 Latin America Recombinant DNA Technology Market Size by Type (2017-2022)
9.2.2 Latin America Recombinant DNA Technology Market Size by Type (2023-2028)
9.2.3 Latin America Recombinant DNA Technology Market Share by Type (2017-2028)
9.3 Latin America Recombinant DNA Technology Market Size by Application
9.3.1 Latin America Recombinant DNA Technology Market Size by Application (2017-2022)
9.3.2 Latin America Recombinant DNA Technology Market Size by Application (2023-2028)
9.3.3 Latin America Recombinant DNA Technology Market Share by Application (2017-2028)
9.4 Latin America Recombinant DNA Technology Market Size by Country
9.4.1 Latin America Recombinant DNA Technology Market Size by Country (2017-2022)
9.4.2 Latin America Recombinant DNA Technology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA Technology Market Size (2017-2028)
10.2 Middle East & Africa Recombinant DNA Technology Market Size by Type
10.2.1 Middle East & Africa Recombinant DNA Technology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Recombinant DNA Technology Market Share by Type (2017-2028)
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Application
10.3.1 Middle East & Africa Recombinant DNA Technology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Recombinant DNA Technology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Recombinant DNA Technology Market Share by Application (2017-2028)
10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country
10.4.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Recombinant DNA Technology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Details
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Introduction
11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2017-2022)
11.1.5 Monsanto Company Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Introduction
11.2.4 Roche Revenue in Recombinant DNA Technology Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Introduction
11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2017-2022)
11.3.5 Biogen Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Introduction
11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2017-2022)
11.4.5 Amgen Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Introduction
11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2017-2022)
11.6.5 Eli Lilly and Company Recent Developments
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Introduction
11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2017-2022)
11.7.5 GenScript Recent Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2017-2022)
11.8.5 Pfizer Inc. Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Introduction
11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2017-2022)
11.9.5 Novo Nordisk Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Introduction
11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2017-2022)
11.10.5 Sanofi Recent Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Introduction
11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2017-2022)
11.11.5 Merck KGaA Recent Developments
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Introduction
11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2017-2022)
11.12.5 Profacgen Recent Developments
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Introduction
11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2017-2022)
11.13.5 Biocon Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2017-2022)
11.14.5 GlaxoSmithKline Recent Developments
11.15 Cibus
11.15.1 Cibus Company Details
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Introduction
11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2017-2022)
11.15.5 Cibus Recent Developments
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Details
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2017-2022)
11.16.5 Horizon Discovery Group Recent Developments
11.17 New England Biolabs
11.17.1 New England Biolabs Company Details
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Introduction
11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2017-2022)
11.17.5 New England Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Recombinant DNA Technology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Recombinant DNA Technology Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Recombinant DNA Technology Market Share by Region (2017-2022)
Table 10. Global Recombinant DNA Technology Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Region (2023-2028)
Table 12. Recombinant DNA Technology Market Trends
Table 13. Recombinant DNA Technology Market Drivers
Table 14. Recombinant DNA Technology Market Challenges
Table 15. Recombinant DNA Technology Market Restraints
Table 16. Global Recombinant DNA Technology Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Recombinant DNA Technology Revenue Share by Players (2017-2022)
Table 18. Global Top Recombinant DNA Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2021)
Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Recombinant DNA Technology Product Solution and Service
Table 23. Date of Enter into Recombinant DNA Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2017-2022)
Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2023-2028)
Table 29. Global Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Recombinant DNA Technology Revenue Share by Application (2017-2022)
Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Recombinant DNA Technology Revenue Share by Application (2023-2028)
Table 33. North America Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Recombinant DNA Technology Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Recombinant DNA Technology Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Recombinant DNA Technology Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Recombinant DNA Technology Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Recombinant DNA Technology Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Recombinant DNA Technology Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Recombinant DNA Technology Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Recombinant DNA Technology Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Recombinant DNA Technology Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Recombinant DNA Technology Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Recombinant DNA Technology Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Recombinant DNA Technology Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Recombinant DNA Technology Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Recombinant DNA Technology Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Recombinant DNA Technology Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Recombinant DNA Technology Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Recombinant DNA Technology Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Recombinant DNA Technology Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Recombinant DNA Technology Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Recombinant DNA Technology Market Size by Country (2023-2028) & (US$ Million)
Table 63. Monsanto Company Company Details
Table 64. Monsanto Company Business Overview
Table 65. Monsanto Company Recombinant DNA Technology Product
Table 66. Monsanto Company Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 67. Monsanto Company Recent Developments
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Recombinant DNA Technology Product
Table 71. Roche Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 72. Roche Recent Developments
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Recombinant DNA Technology Product
Table 76. Biogen Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 77. Biogen Recent Developments
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Recombinant DNA Technology Product
Table 81. Amgen Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 82. Amgen Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Recombinant DNA Technology Product
Table 86. Novartis Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Recombinant DNA Technology Product
Table 91. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 92. Eli Lilly and Company Recent Developments
Table 93. GenScript Company Details
Table 94. GenScript Business Overview
Table 95. GenScript Recombinant DNA Technology Product
Table 96. GenScript Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 97. GenScript Recent Developments
Table 98. Pfizer Inc. Company Details
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Recombinant DNA Technology Product
Table 101. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 102. Pfizer Inc. Recent Developments
Table 103. Novo Nordisk Company Details
Table 104. Novo Nordisk Business Overview
Table 105. Novo Nordisk Recombinant DNA Technology Product
Table 106. Novo Nordisk Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 107. Novo Nordisk Recent Developments
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Recombinant DNA Technology Product
Table 111. Sanofi Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 112. Sanofi Recent Developments
Table 113. Merck KGaA Company Details
Table 114. Merck KGaA Business Overview
Table 115. Merck KGaA Recombinant DNA Technology Product
Table 116. Merck KGaA Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 117. Merck KGaA Recent Developments
Table 118. Profacgen Company Details
Table 119. Profacgen Business Overview
Table 120. Profacgen Recombinant DNA Technology Product
Table 121. Profacgen Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 122. Profacgen Recent Developments
Table 123. Biocon Company Details
Table 124. Biocon Business Overview
Table 125. Biocon Recombinant DNA Technology Product
Table 126. Biocon Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 127. Biocon Recent Developments
Table 128. GlaxoSmithKline Company Details
Table 129. GlaxoSmithKline Business Overview
Table 130. GlaxoSmithKline Recombinant DNA Technology Product
Table 131. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 132. GlaxoSmithKline Recent Developments
Table 133. Cibus Company Details
Table 134. Cibus Business Overview
Table 135. Cibus Recombinant DNA Technology Product
Table 136. Cibus Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 137. Cibus Recent Developments
Table 138. Horizon Discovery Group Company Details
Table 139. Horizon Discovery Group Business Overview
Table 140. Horizon Discovery Group Recombinant DNA Technology Product
Table 141. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 142. Horizon Discovery Group Recent Developments
Table 143. New England Biolabs Company Details
Table 144. New England Biolabs Business Overview
Table 145. New England Biolabs Recombinant DNA Technology Product
Table 146. New England Biolabs Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 147. New England Biolabs Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Market Share by Type: 2021 VS 2028
Figure 2. Therapeutic Agent Features
Figure 3. Vaccine Features
Figure 4. Biotech Crops Features
Figure 5. Specialty Chemicals Features
Figure 6. Global Recombinant DNA Technology Market Share by Application: 2021 VS 2028
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant DNA Technology Report Years Considered
Figure 11. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Recombinant DNA Technology Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Recombinant DNA Technology Market Share by Region: 2021 VS 2028
Figure 14. Global Recombinant DNA Technology Market Share by Players in 2021
Figure 15. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2021
Figure 17. North America Recombinant DNA Technology Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Recombinant DNA Technology Market Size Market Share by Type (2017-2028)
Figure 19. North America Recombinant DNA Technology Market Size Market Share by Application (2017-2028)
Figure 20. North America Recombinant DNA Technology Market Size Share by Country (2017-2028)
Figure 21. United States Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Recombinant DNA Technology Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Recombinant DNA Technology Market Size Market Share by Type (2017-2028)
Figure 25. Europe Recombinant DNA Technology Market Size Market Share by Application (2017-2028)
Figure 26. Europe Recombinant DNA Technology Market Size Share by Country (2017-2028)
Figure 27. Germany Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Recombinant DNA Technology Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Recombinant DNA Technology Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Recombinant DNA Technology Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Recombinant DNA Technology Market Size Share by Region (2017-2028)
Figure 37. China Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Recombinant DNA Technology Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Recombinant DNA Technology Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Recombinant DNA Technology Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Recombinant DNA Technology Market Size Share by Country (2017-2028)
Figure 47. Mexico Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Recombinant DNA Technology Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Recombinant DNA Technology Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Recombinant DNA Technology Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Recombinant DNA Technology Market Size Share by Country (2017-2028)
Figure 53. Turkey Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Recombinant DNA Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 57. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 58. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 59. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 62. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 63. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 64. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 65. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 66. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 67. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 68. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 70. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 71. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 72. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Industry Market Size
